Richard-Carpentier, G. (2023) “Venetoclax-based lower-intensity regimens for acute myeloid leukemia: Clinical pearls for a new standard of care”, Canadian Hematology Today. Toronto, Canada, 2(1), pp. 28–33. doi: 10.58931/cht.2023.2125.